Progressive fibrotic interstitial lung disease
Studies & trials
- AMBOX StudyA prospective, open-label, mixed-method, crossover randomised controlled trial, assessing the effect of oxygen on quality of life for patients with fibrotic lung disease (AmbOx). This study has been published.
- INJUSTIS trialIt’s not Just Idiopathic pulmonary fibrosis study. A prospective study to identify biomarkers and gene expression profiles that determine progressive fibrotic in patients with fibrosing lung disease. This study is currently recruiting.
